Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Sumatriptan

A serotonin 5-HT1B/1D receptor agonist and the first medicine of the triptan class: developed in the United Kingdom, it reached the market in the early 1990s to treat migraine and cluster headache attacks. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards, nitrosamines and other impurities.

Did you know?The suffix -triptan, born with it, became the INN stem for the whole class: it is carried by its successors, such as rizatriptan, zolmitriptan and eletriptan.

SumatriptanGo to the active ingredient →
SumatriptanActive ingredientSumatriptanCat. No. P-S131-001CAS 103628-46-2

EDQM standards 3

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.